Processing Magazine

Louisiana Awarded $20 Million in Eli Lilly Drug Settlement

April 8, 2010

The Associated Press reports that Louisiana will receive $20 million in a settlement with pharmaceutical maker Eli Lilly and Co. over its marketing of the anti-psychotic drug Zyprexa, the state attorney general said Wednesday. Louisiana was one of 13 states that filed individual suits in state courts over allegations that Indianapolis-based Eli Lilly pushed the drug for uses that had not been approved by federal regulators. Louisiana is the 11th state to settle. Other states that have settled are Alaska, West Virginia, Connecticut, Utah, Idaho, South Carolina, New Mexico, Mississippi, Arkansas and Montana. Suit filed by Minnesota and Pennsylvania are pending. Eli Lilly paid a $1.4 billion settlement to the federal government in January 2009 after admitting it had promoted Zyprexa for treatment of dementia in the elderly. Zyprexa has been approved to treat psychological problems such as schizophrenia and bipolar disorders in adults only Louisiana''s suit alleged that Eli Lilly marketed the drug for use with children and in other "off-label" uses as treating depression, attention deficit disorder, sleeping problems, anger and stabilizing moods.